Cas no 76000-08-3 (Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1))
Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) Chemical and Physical Properties
Names and Identifiers
-
- Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1)
- 4-(3-phenylpropyl)piperidine,hydrochloride
- (Phenyl-3 propyl)-4 piperidine chlorhydrate [French]
- 4-(3-phenyl-propyl)piperidine hydrochloride
- 4-(3-PHENYL-PROPYL)-PIPERIDINE HYDROCHLORIDE
- AB09907
- AC1LAX52
- KB-238011
- Piperidine, 4-(3-phenylpropyl)-, hydrochloride
- SureCN7669421
- DTXSID40226909
- 4-(3-PHENYL-PROPYL)-PIPERIDINE HCL
- 4-(3-phenylpropyl)piperidine;hydrochloride
- 76000-08-3
- A838580
- BDA00008
- 4-(3-Phenylpropyl)piperidinehydrochloride
- SCHEMBL7669421
- (Phenyl-3 propyl)-4 piperidine chlorhydrate
- 4-(3-Phenylpropyl)piperidine hydrochloride
- CS-0455563
-
- MDL: MFCD01756609
- Inchi: 1S/C14H21N.ClH/c1-2-5-13(6-3-1)7-4-8-14-9-11-15-12-10-14;/h1-3,5-6,14-15H,4,7-12H2;1H
- InChI Key: DTYWENFVDLKMSK-UHFFFAOYSA-N
- SMILES: Cl.N1CCC(CCCC2C=CC=CC=2)CC1
Computed Properties
- Exact Mass: 239.14400
- Monoisotopic Mass: 239.1440774g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 16
- Rotatable Bond Count: 4
- Complexity: 155
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 12?2
Experimental Properties
- PSA: 12.03000
- LogP: 4.13970
Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) Customs Data
- HS CODE:2933399090
- Customs Data:
China Customs Code:
2933399090Overview:
2933399090. Other compounds with non fused pyridine rings in structure. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 60R0219S-5g |
4-(3-Phenyl-propyl)-piperidine hydrochloride |
76000-08-3 | 98% | 5g |
593.63CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 60R0219S-1g |
4-(3-Phenyl-propyl)-piperidine hydrochloride |
76000-08-3 | 98% | 1g |
169.61CNY | 2021-05-08 | |
| Chemenu | CM181118-5g |
4-(3-Phenyl-propyl)-piperidine hydrochloride |
76000-08-3 | 95% | 5g |
$431 | 2021-08-05 | |
| Chemenu | CM181118-1g |
4-(3-Phenyl-propyl)-piperidine hydrochloride |
76000-08-3 | 95% | 1g |
$163 | 2023-01-09 | |
| Ambeed | A560595-1g |
4-(3-Phenylpropyl)piperidine hydrochloride |
76000-08-3 | 95+% | 1g |
$147.0 | 2024-04-17 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 60R0219S-5g |
4-(3-Phenyl-propyl)-piperidine hydrochloride |
76000-08-3 | 98% | 5g |
¥612.08 | 2025-01-22 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 60R0219S-25g |
4-(3-Phenyl-propyl)-piperidine hydrochloride |
76000-08-3 | 98% | 25g |
¥0.0 | 2025-01-22 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 60R0219S-1g |
4-(3-Phenyl-propyl)-piperidine hydrochloride |
76000-08-3 | 98% | 1g |
¥174.88 | 2025-01-22 |
Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) Related Literature
-
Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
-
Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
Additional information on Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1)
Introduction to Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) and Its Significance in Modern Chemical Research
Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1), with the CAS number 76000-08-3, is a compound of significant interest in the field of chemical and pharmaceutical research. This compound, characterized by its unique structural and chemical properties, has garnered attention for its potential applications in various scientific domains. The presence of a piperidine ring and a 3-phenylpropyl substituent makes it a versatile molecule that can be explored for its pharmacological and synthetic utility.
The piperidine moiety is a six-membered heterocyclic amine, known for its stability and ability to form hydrogen bonds. This feature makes it a valuable component in drug design, particularly in the development of bioactive molecules. The 3-phenylpropyl group adds another layer of complexity, influencing the compound's solubility, metabolic stability, and interaction with biological targets. The hydrochloride salt form ensures enhanced solubility and stability, making it easier to handle and study in various experimental settings.
In recent years, there has been a surge in research focused on developing novel therapeutic agents that leverage the unique properties of piperidine derivatives. One notable area of interest is in the development of antiviral and antibacterial agents. The structural motif of Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) has shown promise in inhibiting certain viral proteases and bacterial enzymes, making it a candidate for further investigation in medicinal chemistry.
Moreover, the compound has been explored in the context of central nervous system (CNS) disorders. Piperidine derivatives are known to interact with various neurotransmitter receptors and enzymes, which are implicated in conditions such as depression, anxiety, and neurodegenerative diseases. The specific substitution pattern in Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) may confer selectivity for certain CNS targets, potentially leading to the development of new treatments.
Recent studies have also highlighted the compound's role in cancer research. The ability of Piperidine derivatives to modulate key signaling pathways involved in cell proliferation and apoptosis makes them attractive candidates for anticancer therapy. Preclinical studies have demonstrated that certain piperidine-based compounds can inhibit the growth of tumor cells by targeting specific molecular mechanisms.
The synthetic pathways for obtaining Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) have been optimized to ensure high yield and purity. Advanced synthetic techniques such as catalytic hydrogenation and nucleophilic substitution reactions have been employed to construct the desired molecular framework. These methods not only enhance the efficiency of synthesis but also allow for modifications that can fine-tune the pharmacological properties of the compound.
In conclusion, Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1) represents a promising molecule with diverse applications in pharmaceutical research. Its unique structural features make it a valuable tool for developing novel therapeutic agents targeting various diseases. As research continues to uncover new applications and refine synthetic methodologies, this compound is poised to play a significant role in advancing chemical and biomedical sciences.
76000-08-3 (Piperidine,4-(3-phenylpropyl)-, hydrochloride (1:1)) Related Products
- 51069-11-5(4-Phenylquinuclidine)
- 24152-41-8(4-(2-phenylethyl)piperidine)
- 59083-39-5(4-(4-Methylphenyl)piperidine)
- 18495-82-4(4-(3-Phenylpropyl)piperidine)
- 111153-83-4(4-(m-tolyl)piperidine)
- 73252-01-4(4-Phenylazepane)
- 19841-73-7(4-Diphenylmethylpiperidine)
- 13603-25-3(3-Benzylpiperidine)
- 771-99-3(4-Phenylpiperidine)
- 31252-42-3(4-Benzylpiperidine)